Companies: 10,793     total market cap: A$194.794 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
BrainStorm Cell Therapeutics
BCLI
#10451
Rank
A$13.77 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
A$1.25
Share price
-9.47%
Change (1 day)
-39.25%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2025 (TTM): A-$2.26

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is A-$2.16. In 2015 the company made an earnings per share (EPS) of A-$9.80 an increase over its 2014 EPS that were of A-$14.80.

EPS history for BrainStorm Cell Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$2.26
2015A-$9.80-33.82%
2014A-$14.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
A$12.81-692.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.94-559.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
A-$5.82 169.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
A-$9.48 338.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A-$4.51 108.72%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com